Publications in collaboration with researchers from Instituto de Investigación Sanitaria del Hospital Universitario La Paz (8)

2021

  1. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches

    Handbook of Experimental Pharmacology (Springer Science and Business Media Deutschland GmbH), pp. 229-259

2020

  1. Melatonin-sulforaphane hybrid ITH12674 attenuates glial response in vivo by blocking LPS binding to MD2 and receptor oligomerization

    Pharmacological Research, Vol. 152

2019

  1. The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation

    Aging Cell, Vol. 18, Núm. 3

2018

  1. MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

    Translational Research, Vol. 200, pp. 1-17

  2. Transcription factor NRF2 as a therapeutic target for chronic diseases: A systems medicine approach

    Pharmacological Reviews, Vol. 70, Núm. 2, pp. 348-383

2017

  1. Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease

    Scientific Reports, Vol. 7

2012

  1. Benzothiazepine CGP37157 and its isosteric 2′-ethyl analogue provide neuroprotection and block cell calcium entry

    ACS Chemical Neuroscience, Vol. 3, Núm. 7, pp. 519-529

2011

  1. Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 12, pp. 6119-6130